OpGen Provides ATM Program Update
December 16 2016 - 9:26AM
OpGen, Inc. (NASDAQ:OPGN) announces that during the fourth quarter
of 2016 it has issued approximately 3.6 million shares of its
common stock under its previously announced “at the market
offering” program, resulting in aggregate net proceeds to the
Company of approximately $4.6 million. The proceeds will be
used to support the company’s research, development and
manufacturing of product candidates, and for other general
corporate purposes.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy the securities, nor shall there be
any sale of the securities in any state in which such offer,
solicitation or sale would be unlawful prior to the registration or
qualification under the securities laws of such state.
About OpGen OpGen, Inc. is harnessing
the power of informatics and genomic analysis to provide complete
solutions for patient, hospital and network-wide infection
prevention and treatment. Learn more at www.opgen.com and
follow OpGen on Twitter and LinkedIn.
OpGen Contact:
Michael Farmer
Director, Marketing
240-813-1284
mfarmer@opgen.com
InvestorRelations@opgen.com
OpGen Investor and Media Contact:
MacDougall Biomedical Communications
Cammy Duong
781-591-3443
cduong@macbiocom.com
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Apr 2023 to Apr 2024